SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-10-036307
Filing Date
2010-07-02
Accepted
2010-07-02 12:00:19
Documents
5
Period of Report
2010-06-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v189774_8k.htm 8-K 28175
2 v189774_ex10-1.htm EX-10.1 75507
3 v189774_ex10-2.htm EX-10.2 61413
4 v189774_ex10-3.htm EX-10.3 42753
5 v189774_ex10-4.htm EX-10.4 48239
  Complete submission text file 0001144204-10-036307.txt   258099
Mailing Address 927 CANADA CT. CITY OF INDUSTRY CA 91748
Business Address 927 CANADA CT. CITY OF INDUSTRY CA 91748 626-581-9098
China Yongxin Pharmaceuticals Inc. (Filer) CIK: 0001087848 (see all company filings)

IRS No.: 880420306 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26293 | Film No.: 10934685
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries